These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36102453)

  • 21. Impact of Weight Regain on the Evolution of Non-alcoholic Fatty Liver Disease After Roux-en-Y Gastric Bypass: a 3-Year Follow-up.
    Jimenez LS; Mendonça Chaim FH; Mendonça Chaim FD; Utrini MP; Gestic MA; Chaim EA; Cazzo E
    Obes Surg; 2018 Oct; 28(10):3131-3135. PubMed ID: 29725976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis.
    Lassailly G; Caiazzo R; Ntandja-Wandji LC; Gnemmi V; Baud G; Verkindt H; Ningarhari M; Louvet A; Leteurtre E; Raverdy V; Dharancy S; Pattou F; Mathurin P
    Gastroenterology; 2020 Oct; 159(4):1290-1301.e5. PubMed ID: 32553765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of bariatric surgery on fatty liver disease in obese patients: A prospective one year follow-up study.
    Toman D; Vavra P; Jelinek P; Ostruszka P; Ihnat P; Foltys A; Pelikan A; Roman J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 May; 166(2):195-203. PubMed ID: 33885048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome of liver transplantation in patients with prior bariatric surgery.
    Safwan M; Collins KM; Abouljoud MS; Salgia R
    Liver Transpl; 2017 Nov; 23(11):1415-1421. PubMed ID: 28752920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease.
    Clark JM; Alkhuraishi AR; Solga SF; Alli P; Diehl AM; Magnuson TH
    Obes Res; 2005 Jul; 13(7):1180-6. PubMed ID: 16076987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term weight loss outcomes after banded Roux-en-Y gastric bypass: a prospective 10-year follow-up study.
    Magro DO; Ueno M; Coelho-Neto JS; Callejas-Neto F; Pareja JC; Cazzo E
    Surg Obes Relat Dis; 2018 Jul; 14(7):910-917. PubMed ID: 29706496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastric Bypass and Influence on Improvement of NAFLD.
    Alli V; Rogers AM
    Curr Gastroenterol Rep; 2017 Jun; 19(6):25. PubMed ID: 28429199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Use of Noninvasive Scores in Predicting NAFLD Progression After Bariatric Surgery.
    Ahmed L; Gebran S; Persaud A; Saeed K; Khan K; Saeed S; Alothman S; Passos-Fox B; DePaz H; Suman P
    Obes Surg; 2023 Dec; 33(12):4026-4033. PubMed ID: 37884692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: "NASHOST" prospective observational trial.
    Praveen Raj P; Gomes RM; Kumar S; Senthilnathan P; Karthikeyan P; Shankar A; Palanivelu C
    Surg Obes Relat Dis; 2015; 11(6):1315-22. PubMed ID: 26003897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastric Bypass Compared with Sleeve Gastrectomy for Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-analysis.
    de Brito E Silva MB; Tustumi F; de Miranda Neto AA; Dantas ACB; Santo MA; Cecconello I
    Obes Surg; 2021 Jun; 31(6):2762-2772. PubMed ID: 33846949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of post-Roux-en-Y gastric bypass weight recidivism on insulin resistance: a 3-year follow-up.
    Concon MM; Jimenez LS; Callejas GH; Chaim EA; Cazzo E
    Surg Obes Relat Dis; 2019 Nov; 15(11):1912-1916. PubMed ID: 31631000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Effect of Roux-en-Y Gastric Bypass on Non-Alcoholic Fatty Liver Disease Fibrosis Assessed by FIB-4 and NFS Scores-An 11.6-Year Follow-Up Study.
    Sandvik ECS; Aasarød KM; Johnsen G; Hoff DAL; Kulseng B; Hyldmo ÅA; Græslie H; Nymo S; Sandvik J; Fossmark R
    J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36013149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DO HELICOBACTER PYLORI INFECTION AND ERADICATION THERAPY STATUS INFLUENCE WEIGHT LOSS OUTCOMES AND ENDOSCOPIC FINDINGS AFTER ROUX-EN-Y GASTRIC BYPASS?A HISTORICAL COHORT STUDY.
    Sia GB; Gestic MA; Utrini MP; Chaim FDM; Chaim EA; Cazzo E
    Arq Gastroenterol; 2023; 60(1):57-64. PubMed ID: 37194781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of Roux-en-Y Gastric Bypass on the Hepatocellular Function and Bile Flow of Obese Patients Assessed by Scintigraphy with DISIDA.
    Salgado Júnior W; Donadelli CA; Dos Santos JS; Nonino CB
    Obes Surg; 2016 Nov; 26(11):2718-2723. PubMed ID: 27094876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How bariatric surgery affects liver volume and fat density in NAFLD patients.
    Luo RB; Suzuki T; Hooker JC; Covarrubias Y; Schlein A; Liu S; Schwimmer JB; Reeder SB; Funk LM; Greenberg JA; Campos GM; Sandler BJ; Horgan S; Sirlin CB; Jacobsen GR
    Surg Endosc; 2018 Apr; 32(4):1675-1682. PubMed ID: 29218660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial.
    Peterli R; Wölnerhanssen BK; Peters T; Vetter D; Kröll D; Borbély Y; Schultes B; Beglinger C; Drewe J; Schiesser M; Nett P; Bueter M
    JAMA; 2018 Jan; 319(3):255-265. PubMed ID: 29340679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis.
    Fakhry TK; Mhaskar R; Schwitalla T; Muradova E; Gonzalvo JP; Murr MM
    Surg Obes Relat Dis; 2019 Mar; 15(3):502-511. PubMed ID: 30683512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic review and meta-analysis of Roux-en-Y gastric bypass against laparoscopic sleeve gastrectomy for amelioration of NAFLD using four criteria.
    Baldwin D; Chennakesavalu M; Gangemi A
    Surg Obes Relat Dis; 2019 Dec; 15(12):2123-2130. PubMed ID: 31711944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roux-en-Y gastric bypass improves the nonalcoholic steatohepatitis (NASH) of morbid obesity.
    de Almeida SR; Rocha PR; Sanches MD; Leite VH; da Silva RA; Diniz MT; Diniz Mde F; Rocha AL
    Obes Surg; 2006 Mar; 16(3):270-8. PubMed ID: 16545157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resolution of nonalcoholic steatohepatits after gastric bypass surgery.
    Liu X; Lazenby AJ; Clements RH; Jhala N; Abrams GA
    Obes Surg; 2007 Apr; 17(4):486-92. PubMed ID: 17608261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.